Literature DB >> 23708834

An alternative direct compound dispensing method using the HP D300 digital dispenser.

Raisa E Jones1, Wei Zheng, John C McKew, Catherine Z Chen.   

Abstract

Evaluation of compound activity in vitro is crucial to drug discovery efforts and require that the compounds be accurately and reliably titrated and dispensed to the assay wells. The HP D300 dispenser uses inkjet technology to achieve small-volume dispensing that allows concentration-response testing using the direct dilution paradigm. Although inkjet technology has been long in existence, it is new to the field of screening and drug development. We have evaluated the D300 dispenser in a biochemical assay, a cell-based reporter gene assay, and a cytotoxicity assay. The software for this instrument is user friendly, and the compound-dispensing process is streamlined. However, a limitation is that this dispenser is currently applicable to only 96-well and 384-well plate formats and not to 1536-well high-density plates. Our results indicate that the D300 generates clean and reproducible results that correlate with those produced with more commonly used instruments such as the pin tool. We found that the instrument is useful and can improve the throughput of compound dispensing in 96-well and 384-well plates.

Entities:  

Keywords:  compound dispenser; compound screen; direct dilution; liquid handler; serial dilution

Mesh:

Year:  2013        PMID: 23708834      PMCID: PMC3985129          DOI: 10.1177/2211068213491094

Source DB:  PubMed          Journal:  J Lab Autom        ISSN: 2211-0682


  8 in total

1.  Achieving accurate compound concentration in cell-based screening: validation of acoustic droplet ejection technology.

Authors:  Richard John Grant; Karen Roberts; Carly Pointon; Clare Hodgson; Lynsey Womersley; Darren Craig Jones; Eric Tang
Journal:  J Biomol Screen       Date:  2009-06-04

2.  Gradient, contact-free volume transfers minimize compound loss in dose-response experiments.

Authors:  David Harris; Joe Olechno; Sammy Datwani; Richard Ellson
Journal:  J Biomol Screen       Date:  2009-12-11

3.  Accelerated transport and maturation of lysosomal alpha-galactosidase A in Fabry lymphoblasts by an enzyme inhibitor.

Authors:  J Q Fan; S Ishii; N Asano; Y Suzuki
Journal:  Nat Med       Date:  1999-01       Impact factor: 53.440

4.  A bioluminescent cytotoxicity assay for assessment of membrane integrity using a proteolytic biomarker.

Authors:  Ming-Hsuang Cho; Andrew Niles; Ruili Huang; James Inglese; Christopher P Austin; Terry Riss; Menghang Xia
Journal:  Toxicol In Vitro       Date:  2008-03-04       Impact factor: 3.500

5.  Synthesis and characterization of a new fluorogenic substrate for alpha-galactosidase.

Authors:  Zhen-Dan Shi; Omid Motabar; Ehud Goldin; Ke Liu; Noel Southall; Ellen Sidransky; Christopher P Austin; Gary L Griffiths; Wei Zheng
Journal:  Anal Bioanal Chem       Date:  2009-06-13       Impact factor: 4.142

6.  High throughput screening for inhibitors of alpha-galactosidase.

Authors:  Omid Motabar; Ke Liu; Noel Southall; Juan J Marugan; Ehud Goldin; Ellen Sidransky; Wei Zheng
Journal:  Curr Chem Genomics       Date:  2010-12-03

7.  Compound cytotoxicity profiling using quantitative high-throughput screening.

Authors:  Menghang Xia; Ruili Huang; Kristine L Witt; Noel Southall; Jennifer Fostel; Ming-Hsuang Cho; Ajit Jadhav; Cynthia S Smith; James Inglese; Christopher J Portier; Raymond R Tice; Christopher P Austin
Journal:  Environ Health Perspect       Date:  2008-03       Impact factor: 9.031

8.  Glucocorticoids with different chemical structures but similar glucocorticoid receptor potency regulate subsets of common and unique genes in human trabecular meshwork cells.

Authors:  Alissar Nehmé; Edward K Lobenhofer; W Daniel Stamer; Jeffrey L Edelman
Journal:  BMC Med Genomics       Date:  2009-09-10       Impact factor: 3.063

  8 in total
  8 in total

1.  Repurposing Kinase Inhibitors as Antiviral Agents to Control Influenza A Virus Replication.

Authors:  Olivia Perwitasari; Xiuzhen Yan; Jason O'Donnell; Scott Johnson; Ralph A Tripp
Journal:  Assay Drug Dev Technol       Date:  2015-07-20       Impact factor: 1.738

2.  High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity.

Authors:  Lucius Chiaraviglio; Yoon-Suk Kang; James E Kirby
Journal:  J Vis Exp       Date:  2016-11-16       Impact factor: 1.355

Review 3.  Emerging Technologies in Multi-Material Bioprinting.

Authors:  Hossein Ravanbakhsh; Vahid Karamzadeh; Guangyu Bao; Luc Mongeau; David Juncker; Yu Shrike Zhang
Journal:  Adv Mater       Date:  2021-10-01       Impact factor: 32.086

4.  Verdinexor, a novel selective inhibitor of nuclear export, reduces influenza a virus replication in vitro and in vivo.

Authors:  Olivia Perwitasari; Scott Johnson; Xiuzhen Yan; Elizabeth Howerth; Sharon Shacham; Yosef Landesman; Erkan Baloglu; Dilara McCauley; Sharon Tamir; S Mark Tompkins; Ralph A Tripp
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

5.  Optimizing multi-dimensional high throughput screening using zebrafish.

Authors:  Lisa Truong; Sean M Bugel; Anna Chlebowski; Crystal Y Usenko; Michael T Simonich; Staci L Massey Simonich; Robert L Tanguay
Journal:  Reprod Toxicol       Date:  2016-07-21       Impact factor: 3.143

6.  Targeting cell division cycle 25 homolog B to regulate influenza virus replication.

Authors:  Olivia Perwitasari; Ana Claudia Torrecilhas; Xiuzhen Yan; Scott Johnson; Caleb White; S Mark Tompkins; Ralph A Tripp
Journal:  J Virol       Date:  2013-10-09       Impact factor: 5.103

7.  Modeling error in experimental assays using the bootstrap principle: understanding discrepancies between assays using different dispensing technologies.

Authors:  Sonya M Hanson; Sean Ekins; John D Chodera
Journal:  J Comput Aided Mol Des       Date:  2015-12-17       Impact factor: 3.686

8.  The future of skin toxicology testing - Three-dimensional bioprinting meets microfluidics.

Authors:  Wei Long Ng; Wai Yee Yeong
Journal:  Int J Bioprint       Date:  2019-09-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.